FILINGS
REGN 0000872589 | |||
---|---|---|---|
Filing Date | Form Type | Description | Document |
2024-05-06 | 4 | PRIMARY DOCUMENT | View Document |
2024-05-03 | 4 | PRIMARY DOCUMENT | View Document |
2024-05-03 | 4 | PRIMARY DOCUMENT | View Document |
2024-05-02 | 10-Q | 10-Q | View Document |
2024-05-02 | 8-K | 8-K | View Document |
2024-05-01 | 144 | View Document | |
2024-05-01 | 144 | View Document | |
2024-05-01 | 4 | PRIMARY DOCUMENT | View Document |
2024-05-01 | 4 | PRIMARY DOCUMENT | View Document |
2024-04-25 | ARS | ARS | View Document |
2024-04-25 | DEFA14A | REGENERON PHARMACEUTICALS, INC. - DEFA14A | View Document |
2024-04-25 | DEF 14A | REGENERON PHARMACEUTICALS, INC. - DEF 14A | View Document |
2024-04-03 | 4 | PRIMARY DOCUMENT | View Document |
2024-04-03 | 4 | PRIMARY DOCUMENT | View Document |
2024-04-01 | 144 | View Document | |
2024-03-15 | 4 | PRIMARY DOCUMENT | View Document |
2024-03-14 | 144 | View Document | |
2024-03-05 | 4 | PRIMARY DOCUMENT | View Document |
2024-03-05 | 4 | PRIMARY DOCUMENT | View Document |
2024-03-01 | 144 | View Document | |
2024-02-28 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-28 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-28 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-26 | 144 | View Document | |
2024-02-26 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-26 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-26 | 144 | View Document | |
2024-02-26 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-26 | 144 | View Document | |
2024-02-23 | 144 | View Document | |
2024-02-22 | 144 | View Document | |
2024-02-22 | 144 | View Document | |
2024-02-20 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-16 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-14 | 144 | View Document | |
2024-02-13 | SC 13G/A | SCHEDULE 13G/A | View Document |
2024-02-13 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-12 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-12 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-09 | SC 13G/A | SEC SCHEDULE 13G | View Document |
2024-02-09 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-09 | 144 | View Document | |
2024-02-09 | 144 | View Document | |
2024-02-09 | SC 13G/A | View Document | |
2024-02-08 | 144 | View Document | |
2024-02-08 | 144 | View Document | |
2024-02-08 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-08 | 3 | OWNERSHIP DOCUMENT | View Document |
2024-02-07 | 144 | View Document | |
2024-02-07 | 144 | View Document | |
2024-02-07 | 144 | View Document | |
2024-02-06 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-06 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-06 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-05 | 144 | View Document | |
2024-02-05 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-05 | 10-K | 10-K | View Document |
2024-02-02 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-02 | 4 | PRIMARY DOCUMENT | View Document |
2024-02-02 | 8-K | 8-K | View Document |
2024-02-01 | 144 | View Document | |
2024-02-01 | 144 | View Document | |
2024-01-31 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-31 | 8-K | FORM 8-K | View Document |
2024-01-30 | 144 | View Document | |
2024-01-25 | SC 13G/A | View Document | |
2024-01-25 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-25 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-25 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-25 | SC 13G/A | FILING REGENERON PHARMACEUTICALS, INC. | View Document |
2024-01-25 | SC 13G/A | FILING REGENERON PHARMACEUTICALS, INC. | View Document |
2024-01-23 | 144 | View Document | |
2024-01-18 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-17 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-08 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-08 | 8-K | FORM 8-K | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-04 | 4 | PRIMARY DOCUMENT | View Document |
2024-01-03 | 144 | View Document | |
2024-01-02 | 144 | View Document | |
2024-01-02 | 144 | View Document | |
2024-01-02 | 144 | View Document | |
2023-12-29 | 4 | PRIMARY DOCUMENT | View Document |
2023-12-29 | 4 | PRIMARY DOCUMENT | View Document |
2023-12-29 | 4 | PRIMARY DOCUMENT | View Document |
2023-12-27 | 144 | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.